However, its primary action in CPVT was initially attributed to direct modulation of RyR2 and consequent suppression of spontaneous SR Ca2+ waves (Hilliard et al., 2010; Savio-Galimberti and Knollmann, 2015). The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.